8-KItem 7.01 · Reg FD Disclosure
Centene Reaffirms 2026 EPS Guidance Ahead of Deutsche Bank Summit
Filed with the SEC on · Summarized by InvestorsBot
Centene said management will discuss its business and financial results at the Deutsche Bank 2026 Healthcare Summit on September 16 and in investor meetings during the week of September 21. The company reaffirmed full-year 2026 GAAP diluted EPS guidance of greater than $3.11 and adjusted diluted EPS guidance of greater than $4.80; the guidance is effective through September 25, 2026, unless updated or reaffirmed publicly.